Hui Sheng

2.1k total citations
34 papers, 1.2k citations indexed

About

Hui Sheng is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hui Sheng has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Hui Sheng's work include Colorectal Cancer Treatments and Studies (4 papers), RNA modifications and cancer (4 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Hui Sheng is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), RNA modifications and cancer (4 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Hui Sheng collaborates with scholars based in China, United States and Hong Kong. Hui Sheng's co-authors include Rui‐Hua Xu, Huai‐Qiang Ju, Zhao-Lei Zeng, Zexian Liu, Feng Wang, Yun-Xin Lu, Dan Xie, Ying Jin, De‐Shen Wang and Minjie Mao and has published in prestigious journals such as Nature Communications, Molecular Cell and Cancer Research.

In The Last Decade

Hui Sheng

33 papers receiving 1.2k citations

Peers

Hui Sheng

PRM

ONCOL

SURGE

Junichi Asakuma Japan

Lingao Ju China

Yi-Qing Qu China

Rhonda J. Staversky United States

Shinji Ohki Japan

Valentina Grossi Italy

Bae Kwon Jeong South Korea

Kiyoshi Asada Japan

Kai Lee Yap United States

Joseph M. Giaconia United States

Junichi Asakuma Japan

Hui Sheng

485 ×0.8

246 ×0.6

270 ×0.7

PRM

278 ×0.8

ONCOL

219 ×1.7

SURGE

Citations per year, relative to Hui Sheng Hui Sheng (= 1×) peers Junichi Asakuma

Countries citing papers authored by Hui Sheng

Since Specialization

Citations

This map shows the geographic impact of Hui Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Sheng more than expected).

Fields of papers citing papers by Hui Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Sheng. The network helps show where Hui Sheng may publish in the future.

Co-authorship network of co-authors of Hui Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Sheng. A scholar is included among the top collaborators of Hui Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Sheng. Hui Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Jin‐Fei, Zexian Liu, Dongliang Chen, et al.. (2025). Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function. Nature Communications. 16(1). 263–263. 4 indexed citations

Sheng, Hui, et al.. (2024). Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients. Translational Lung Cancer Research. 13(3). 453–464. 2 indexed citations

Tian, Tian, Yongqiang Zheng, Hai‐Yu Mo, et al.. (2023). The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nature Communications. 14(1). 6690–6690. 44 indexed citations

Tan, Wencheng, Minjie Mao, Haoqiang He, et al.. (2023). Endonasopharyngeal ultrasound and magnetic resonance imaging features of recurrent retropharyngeal nodes in nasopharyngeal carcinoma patients: A radiologic-histopathologic study. Radiotherapy and Oncology. 183. 109579–109579. 3 indexed citations

Han, Yi, Yanyu Zhang, Xiaojun Zheng, et al.. (2023). IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance. Molecular Cell. 83(11). 1887–1902.e8. 73 indexed citations

Liu, Zexian, Zhao-Lei Zeng, Xiao-Jing Luo, et al.. (2022). The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer. Cancer Research. 83(9). 1476–1489. 37 indexed citations

Yao, Qiulin, Meifang Tang, Zhonghua Chu, et al.. (2021). Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer. BMC Microbiology. 21(1). 156–156. 10 indexed citations

Chen, Dongliang, Hui Sheng, Dongsheng Zhang, et al.. (2021). The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Molecular Cancer. 20(1). 166–166. 101 indexed citations

Liu, Zekun, Qi Zhao, Zhixiang Zuo, et al.. (2020). Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer. iScience. 23(7). 101302–101302. 163 indexed citations

10.

Mao, Minjie, Xueping Wang, Hui Sheng, et al.. (2020). Heat Shock Protein 90α Provides an Effective and Novel Diagnosis Strategy for Nasopharyngeal Carcinoma. Advances in Therapy. 38(1). 413–422. 9 indexed citations

11.

Liu, Wen, Huilan Li, Hui Sheng, et al.. (2020). A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma. Advances in Therapy. 37(10). 4280–4290. 9 indexed citations

12.

Sheng, Hui, et al.. (2020). The Survival Advantage of Females at Premenopausal Age Is Race Dependent in Colorectal Cancer. BioMed Research International. 2020(1). 7434783–7434783. 4 indexed citations

13.

Sheng, Hui, Xiaoli Wei, Minjie Mao, et al.. (2019). Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer. BMC Cancer. 19(1). 1071–1071. 17 indexed citations

14.

Luo, Hui, Zhe Yang, Wei Wei, et al.. (2018). Enzymatically synthesized poly(amino-co-ester) polyplexes for systemic delivery of pcDNA-miRNA-214 to suppress colorectal cancer liver metastasis. Journal of Materials Chemistry B. 6(40). 6365–6376. 8 indexed citations

15.

Mao, Minjie, Xueping Wang, Hui Sheng, et al.. (2018). A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC Cancer. 18(1). 1178–1178. 22 indexed citations

16.

Lu, Yun-Xin, Qi-Nian Wu, Dong-liang Chen, et al.. (2018). Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation. Theranostics. 8(5). 1312–1326. 51 indexed citations

17.

Wu, Qi-Nian, Yun-Xin Lu, Yun Wang, et al.. (2017). Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance. Cancer Letters. 412. 243–255. 72 indexed citations

18.

Qiu, Miao‐Zhen, Min Chen, Jing Wang, et al.. (2017). Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer. Journal of Cancer. 8(17). 3531–3537. 22 indexed citations

19.

Lu, Yun-Xin, Dong-liang Chen, De‐Shen Wang, et al.. (2016). Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway. Cell Death and Disease. 7(10). e2432–e2432. 51 indexed citations

20.

Wang, Yun, Yang Zhao, Ma-Yan Huang, et al.. (2015). Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer. Oncology Reports. 34(4). 2106–2114. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact